UNSPSC 51263309: Idralfidine

This classification denotes an alpha-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E2U4W02TMR. European Medicines Agency schedules Idralfidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08118MIG. Idralfidine generally arises in the molecular formula C11H14N4O.

UNSPSC 51263309 Idralfidine, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with response due July 26, 2023—solicits Naloxone and Safe Drug Deactivation Systems, products unrelated to the code's nominal pharmaceutical scope. The mismatch suggests either a data-entry error in the opportunity's UNSPSC tagging or that the code itself is used inconsistently by procurement offices. Without additional recent opportunities clearly aligned with idralfidine procurement, the code shows no actionable activity for business development purposes at this time.

The Seminole County opportunity does establish that Florida health authorities are active in pharmaceutical and drug-safety product procurement, but this single instance does not indicate a broader market pattern under the idralfidine code. Firms should verify UNSPSC alignment with procurement offices before pursuing opportunities tagged to this code, as the current record suggests tagging may not reflect the actual commodity being bought.